Literature DB >> 36122330

Evaluating Verbal Fluency Outcome Measures in Children With Down Syndrome.

Catelyn N Smeyne1, Anna J Esbensen2, Emily K Schworer3, Shequanna Belizaire3, Emily K Hoffman3, Dean W Beebe4, Susan Wiley5.   

Abstract

This study evaluates the psychometric properties of a verbal fluency task for potential use as an outcome measure in future clinical trials involving children with Down syndrome. Eighty-five participants attempted a modified version of the Neuropsychological Assessment of Children, Second Edition Word Generation Task at two time points. In the full sample, the measure fell below a priori reliability and feasibility criteria, though feasibility of the semantic trials were higher than feasibility of the phonemic trials. Performance on the measure correlated with chronological age and IQ scores, and no sex-related effects were found. Additional analyses suggested that the semantic verbal fluency trials might be appropriate for children with Down syndrome 10 years of age and older. ©AAIDD.

Entities:  

Keywords:  Down syndrome; adolescents; children; outcome measures; verbal fluency

Mesh:

Year:  2022        PMID: 36122330      PMCID: PMC9487840          DOI: 10.1352/1944-7558-127.4.328

Source DB:  PubMed          Journal:  Am J Intellect Dev Disabil        ISSN: 1944-7558


  44 in total

1.  Short test of semantic and phonological fluency: normal performance, validity and test-retest reliability.

Authors:  J E Harrison; P Buxton; M Husain; R Wise
Journal:  Br J Clin Psychol       Date:  2000-06

2.  The neuropsychology of Down syndrome: evidence for hippocampal dysfunction.

Authors:  Bruce F Pennington; Jennifer Moon; Jamie Edgin; Jennifer Stedron; Lynn Nadel
Journal:  Child Dev       Date:  2003 Jan-Feb

3.  Developmental aspects of verbal fluency and confrontation naming in children.

Authors:  D Riva; F Nichelli; M Devoti
Journal:  Brain Lang       Date:  2000-02-01       Impact factor: 2.381

Review 4.  Clinical trials in children with Down syndrome: issues from a cognitive research perspective.

Authors:  James H Heller; Gail A Spiridigliozzi; Blythe G Crissman; Jennifer A Sullivan-Saarela; Jennifer S Li; Priya S Kishnani
Journal:  Am J Med Genet C Semin Med Genet       Date:  2006-08-15       Impact factor: 3.908

5.  A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research.

Authors:  Terry K Koo; Mae Y Li
Journal:  J Chiropr Med       Date:  2016-03-31

6.  Effects of a naturalistic sign intervention on expressive language of toddlers with Down syndrome.

Authors:  Courtney A Wright; Ann P Kaiser; Dawn I Reikowsky; Megan Y Roberts
Journal:  J Speech Lang Hear Res       Date:  2012-12-28       Impact factor: 2.297

7.  The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity.

Authors:  C Randolph; M C Tierney; E Mohr; T N Chase
Journal:  J Clin Exp Neuropsychol       Date:  1998-06       Impact factor: 2.475

8.  Development and validation of the Arizona Cognitive Test Battery for Down syndrome.

Authors:  Jamie O Edgin; Gina M Mason; Melissa J Allman; George T Capone; Iser Deleon; Cheryl Maslen; Roger H Reeves; Stephanie L Sherman; Lynn Nadel
Journal:  J Neurodev Disord       Date:  2010-09-01       Impact factor: 4.025

9.  Speech and motor speech disorders and intelligibility in adolescents with Down syndrome.

Authors:  Erin M Wilson; Leonard Abbeduto; Stephen M Camarata; Lawrence D Shriberg
Journal:  Clin Linguist Phon       Date:  2019       Impact factor: 1.346

10.  Spoken language outcome measures for treatment studies in Down syndrome: feasibility, practice effects, test-retest reliability, and construct validity of variables generated from expressive language sampling.

Authors:  Angela John Thurman; Jamie O Edgin; Stephanie L Sherman; Audra Sterling; Andrea McDuffie; Elizabeth Berry-Kravis; Debra Hamilton; Leonard Abbeduto
Journal:  J Neurodev Disord       Date:  2021-04-08       Impact factor: 4.025

View more
  1 in total

1.  Considerations for measuring individual outcomes across contexts in Down syndrome: Implications for research and clinical trials.

Authors:  Anna J Esbensen; Emily K Schworer; Deborah J Fidler; Angela John Thurman
Journal:  Int Rev Res Dev Disabil       Date:  2022-08-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.